HEADER SIGNALING PROTEIN 06-DEC-22 8FEC TITLE STRUCTURE OF J-PKAC CHIMERA COMPLEXED WITH APLITHIANINE DERIVATIVE COMPND MOL_ID: 1; COMPND 2 MOLECULE: DNAJ HOMOLOG SUBFAMILY B MEMBER 1,CAMP-DEPENDENT PROTEIN COMPND 3 KINASE CATALYTIC SUBUNIT ALPHA; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: DNAJ PROTEIN HOMOLOG 1,HEAT SHOCK 40 KDA PROTEIN 1,HEAT COMPND 6 SHOCK PROTEIN 40,HUMAN DNAJ PROTEIN 1,HDJ-1,PKA C-ALPHA; COMPND 7 EC: 2.7.11.11; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE INHIBITOR ALPHA; COMPND 11 CHAIN: I, J; COMPND 12 SYNONYM: PKI-ALPHA,CAMP-DEPENDENT PROTEIN KINASE INHIBITOR, COMPND 13 MUSCLE/BRAIN ISOFORM; COMPND 14 ENGINEERED: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: DNAJ HOMOLOG SUBFAMILY B MEMBER 1,CAMP-DEPENDENT PROTEIN COMPND 17 KINASE CATALYTIC SUBUNIT ALPHA; COMPND 18 CHAIN: B; COMPND 19 SYNONYM: DNAJ PROTEIN HOMOLOG 1,HEAT SHOCK 40 KDA PROTEIN 1,HSP40, COMPND 20 HEAT SHOCK PROTEIN 40,HUMAN DNAJ PROTEIN 1,HDJ-1,PKA C-ALPHA; COMPND 21 EC: 2.7.11.11; COMPND 22 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DNAJB1, DNAJ1, HDJ1, HSPF1, PRKACA, PKACA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: BL21*(DE3); SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 MOL_ID: 3; SOURCE 15 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 16 ORGANISM_COMMON: HUMAN; SOURCE 17 ORGANISM_TAXID: 9606; SOURCE 18 GENE: DNAJB1, DNAJ1, HDJ1, HSPF1, PRKACA, PKACA; SOURCE 19 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 20 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 21 EXPRESSION_SYSTEM_VARIANT: BL21*(DE3) KEYWDS PROTEIN KINASE A, FIBROLAMELLAR HEPATOCELLULAR CARCINOMA, NATURAL KEYWDS 2 PRODUCT, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR L.DU,B.A.P.WILSON,N.LI,J.A.MARTINEZ FIESCO,M.DALILIAN,D.WANG, AUTHOR 2 E.A.SMITH,A.WAMIRU,E.I.GONCHAROVA,P.ZHANG,B.R.O'KEEFE REVDAT 2 01-MAY-24 8FEC 1 JRNL REVDAT 1 18-OCT-23 8FEC 0 JRNL AUTH L.DU,B.A.P.WILSON,N.LI,R.SHAH,M.DALILIAN,D.WANG,E.A.SMITH, JRNL AUTH 2 A.WAMIRU,E.I.GONCHAROVA,P.ZHANG,B.R.O'KEEFE JRNL TITL DISCOVERY AND SYNTHESIS OF A NATURALLY DERIVED PROTEIN JRNL TITL 2 KINASE INHIBITOR THAT SELECTIVELY INHIBITS DISTINCT CLASSES JRNL TITL 3 OF SERINE/THREONINE KINASES. JRNL REF J.NAT.PROD. V. 86 2283 2023 JRNL REFN ESSN 1520-6025 JRNL PMID 37843072 JRNL DOI 10.1021/ACS.JNATPROD.3C00394 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.53 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.980 REMARK 3 COMPLETENESS FOR RANGE (%) : 82.4 REMARK 3 NUMBER OF REFLECTIONS : 26352 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.287 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.490 REMARK 3 FREE R VALUE TEST SET COUNT : 3583 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 50.5300 - 7.9800 0.82 1694 156 0.1480 0.1828 REMARK 3 2 7.9800 - 6.3400 0.85 1749 130 0.1716 0.2534 REMARK 3 3 6.3300 - 5.5400 0.89 1807 170 0.1953 0.2672 REMARK 3 4 5.5400 - 5.0300 0.88 1816 150 0.1793 0.2450 REMARK 3 5 5.0300 - 4.6700 0.87 1771 156 0.1556 0.2683 REMARK 3 6 4.6700 - 4.4000 0.72 1525 104 0.1633 0.2618 REMARK 3 7 4.3900 - 4.1700 0.80 1634 128 0.1691 0.2508 REMARK 3 8 4.1700 - 3.9900 0.82 1711 143 0.1983 0.3044 REMARK 3 9 3.9900 - 3.8400 0.84 1757 134 0.2024 0.2962 REMARK 3 10 3.8400 - 3.7100 0.83 1677 139 0.2160 0.3277 REMARK 3 11 3.7100 - 3.5900 0.84 1757 135 0.2190 0.2610 REMARK 3 12 3.5900 - 3.4900 0.85 1767 142 0.2303 0.3168 REMARK 3 13 3.4900 - 3.4000 0.86 1813 122 0.2513 0.2903 REMARK 3 14 3.4000 - 3.3100 0.86 1776 160 0.2507 0.3662 REMARK 3 15 3.3100 - 3.2400 0.86 1774 133 0.2728 0.3812 REMARK 3 16 3.2400 - 3.1700 0.82 1679 141 0.2871 0.3805 REMARK 3 17 3.1700 - 3.1100 0.72 1492 131 0.2818 0.3327 REMARK 3 18 3.1100 - 3.0500 0.77 1648 116 0.2913 0.3789 REMARK 3 19 3.0500 - 2.9900 0.79 1536 134 0.2773 0.3803 REMARK 3 20 2.9900 - 2.9400 0.80 1697 154 0.2646 0.3233 REMARK 3 21 2.9400 - 2.9000 0.82 1689 142 0.2646 0.3529 REMARK 3 22 2.8900 - 2.8500 0.83 1715 132 0.2662 0.4025 REMARK 3 23 2.8500 - 2.8100 0.82 1618 123 0.3134 0.3517 REMARK 3 24 2.8100 - 2.7700 0.83 1836 101 0.3282 0.4081 REMARK 3 25 2.7700 - 2.7300 0.83 1703 151 0.3677 0.4267 REMARK 3 26 2.7300 - 2.7000 0.82 1629 156 0.4005 0.5019 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.479 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 34.808 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 67.13 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 77.68 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 7244 REMARK 3 ANGLE : 1.062 9769 REMARK 3 CHIRALITY : 0.053 998 REMARK 3 PLANARITY : 0.008 1256 REMARK 3 DIHEDRAL : 11.266 969 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8FEC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-DEC-22. REMARK 100 THE DEPOSITION ID IS D_1000270540. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-SEP-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26373 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.530 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.1 REMARK 200 DATA REDUNDANCY : 1.900 REMARK 200 R MERGE (I) : 0.03700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.1700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.1 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : 0.32200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.040 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4WB7 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.93 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.73 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 200 MM LITHIUM SULFATE, 100 MM HEPES REMARK 280 7.5, 25% PEG 3350, PH 7.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2060 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20120 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1940 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20720 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 GLY B 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 12 -8.19 -46.73 REMARK 500 ASN A 35 45.59 -107.59 REMARK 500 GLU A 37 -71.64 -127.39 REMARK 500 ILE A 101 -95.13 -91.19 REMARK 500 PHE A 109 -109.66 -63.63 REMARK 500 GLU A 119 -74.79 -78.68 REMARK 500 PHE A 165 165.05 179.65 REMARK 500 ASP A 167 -159.34 -119.90 REMARK 500 ASP A 221 31.24 -144.17 REMARK 500 ASP A 239 90.42 61.84 REMARK 500 ASN A 271 -169.66 -125.74 REMARK 500 ALA A 295 160.89 172.96 REMARK 500 LEU A 328 43.37 -89.35 REMARK 500 ASN A 348 46.70 -90.77 REMARK 500 PRO A 368 4.65 -64.12 REMARK 500 PHE A 369 105.55 -161.29 REMARK 500 SER B 15 -179.02 -66.27 REMARK 500 TYR B 30 10.89 -146.20 REMARK 500 ASP B 33 40.15 -80.70 REMARK 500 LYS B 34 -8.94 -158.56 REMARK 500 PRO B 38 -77.56 -50.50 REMARK 500 ARG B 58 -72.76 -68.81 REMARK 500 ILE B 101 -91.80 -107.13 REMARK 500 PHE B 109 -72.78 -57.76 REMARK 500 ARG B 111 136.08 170.97 REMARK 500 GLU B 119 -68.36 -93.19 REMARK 500 LYS B 138 56.68 34.96 REMARK 500 PHE B 165 -179.44 -172.62 REMARK 500 ASP B 167 -161.11 -111.91 REMARK 500 ASP B 221 35.30 -140.53 REMARK 500 ASP B 239 92.72 68.29 REMARK 500 LEU B 253 96.52 -61.64 REMARK 500 ASN B 271 -162.94 -120.68 REMARK 500 ALA B 288 -56.10 -126.35 REMARK 500 ALA B 295 156.84 159.96 REMARK 500 HIS B 315 38.88 -81.49 REMARK 500 LEU B 328 36.60 -88.26 REMARK 500 PRO B 371 -166.33 -74.66 REMARK 500 LYS B 374 47.33 -83.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8FE2 RELATED DB: PDB REMARK 900 8FE2 CONTAINS THE SAME PROTEIN COMPLEXED WITH APLITHIANINE A REMARK 900 RELATED ID: 8FE5 RELATED DB: PDB REMARK 900 8FE5 CONTAINS THE SAME PROTEIN COMPLEXED WITH APLITHIANINE B DBREF 8FEC A 1 69 UNP P25685 DNJB1_HUMAN 2 70 DBREF 8FEC A 70 405 UNP P17612 KAPCA_HUMAN 16 351 DBREF 8FEC I 5 24 UNP P61925 IPKA_HUMAN 6 25 DBREF 8FEC B 1 69 UNP P25685 DNJB1_HUMAN 2 70 DBREF 8FEC B 70 405 UNP P17612 KAPCA_HUMAN 16 351 DBREF 8FEC J 5 24 UNP P61925 IPKA_HUMAN 6 25 SEQRES 1 A 405 GLY LYS ASP TYR TYR GLN THR LEU GLY LEU ALA ARG GLY SEQRES 2 A 405 ALA SER ASP GLU GLU ILE LYS ARG ALA TYR ARG ARG GLN SEQRES 3 A 405 ALA LEU ARG TYR HIS PRO ASP LYS ASN LYS GLU PRO GLY SEQRES 4 A 405 ALA GLU GLU LYS PHE LYS GLU ILE ALA GLU ALA TYR ASP SEQRES 5 A 405 VAL LEU SER ASP PRO ARG LYS ARG GLU ILE PHE ASP ARG SEQRES 6 A 405 TYR GLY GLU GLU VAL LYS GLU PHE LEU ALA LYS ALA LYS SEQRES 7 A 405 GLU ASP PHE LEU LYS LYS TRP GLU SER PRO ALA GLN ASN SEQRES 8 A 405 THR ALA HIS LEU ASP GLN PHE GLU ARG ILE LYS THR LEU SEQRES 9 A 405 GLY THR GLY SER PHE GLY ARG VAL MET LEU VAL LYS HIS SEQRES 10 A 405 LYS GLU THR GLY ASN HIS TYR ALA MET LYS ILE LEU ASP SEQRES 11 A 405 LYS GLN LYS VAL VAL LYS LEU LYS GLN ILE GLU HIS THR SEQRES 12 A 405 LEU ASN GLU LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO SEQRES 13 A 405 PHE LEU VAL LYS LEU GLU PHE SER PHE LYS ASP ASN SER SEQRES 14 A 405 ASN LEU TYR MET VAL MET GLU TYR VAL PRO GLY GLY GLU SEQRES 15 A 405 MET PHE SER HIS LEU ARG ARG ILE GLY ARG PHE SEP GLU SEQRES 16 A 405 PRO HIS ALA ARG PHE TYR ALA ALA GLN ILE VAL LEU THR SEQRES 17 A 405 PHE GLU TYR LEU HIS SER LEU ASP LEU ILE TYR ARG ASP SEQRES 18 A 405 LEU LYS PRO GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR SEQRES 19 A 405 ILE GLN VAL THR ASP PHE GLY PHE ALA LYS ARG VAL LYS SEQRES 20 A 405 GLY ARG THR TRP TPO LEU CYS GLY THR PRO GLU TYR LEU SEQRES 21 A 405 ALA PRO GLU ILE ILE LEU SER LYS GLY TYR ASN LYS ALA SEQRES 22 A 405 VAL ASP TRP TRP ALA LEU GLY VAL LEU ILE TYR GLU MET SEQRES 23 A 405 ALA ALA GLY TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE SEQRES 24 A 405 GLN ILE TYR GLU LYS ILE VAL SER GLY LYS VAL ARG PHE SEQRES 25 A 405 PRO SER HIS PHE SER SER ASP LEU LYS ASP LEU LEU ARG SEQRES 26 A 405 ASN LEU LEU GLN VAL ASP LEU THR LYS ARG PHE GLY ASN SEQRES 27 A 405 LEU LYS ASN GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP SEQRES 28 A 405 PHE ALA THR THR ASP TRP ILE ALA ILE TYR GLN ARG LYS SEQRES 29 A 405 VAL GLU ALA PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY SEQRES 30 A 405 ASP THR SER ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE SEQRES 31 A 405 ARG VAL SEP ILE ASN GLU LYS CYS GLY LYS GLU PHE SER SEQRES 32 A 405 GLU PHE SEQRES 1 I 20 THR THR TYR ALA ASP PHE ILE ALA SER GLY ARG THR GLY SEQRES 2 I 20 ARG ARG ASN ALA ILE HIS ASP SEQRES 1 B 405 GLY LYS ASP TYR TYR GLN THR LEU GLY LEU ALA ARG GLY SEQRES 2 B 405 ALA SER ASP GLU GLU ILE LYS ARG ALA TYR ARG ARG GLN SEQRES 3 B 405 ALA LEU ARG TYR HIS PRO ASP LYS ASN LYS GLU PRO GLY SEQRES 4 B 405 ALA GLU GLU LYS PHE LYS GLU ILE ALA GLU ALA TYR ASP SEQRES 5 B 405 VAL LEU SER ASP PRO ARG LYS ARG GLU ILE PHE ASP ARG SEQRES 6 B 405 TYR GLY GLU GLU VAL LYS GLU PHE LEU ALA LYS ALA LYS SEQRES 7 B 405 GLU ASP PHE LEU LYS LYS TRP GLU SER PRO ALA GLN ASN SEQRES 8 B 405 THR ALA HIS LEU ASP GLN PHE GLU ARG ILE LYS THR LEU SEQRES 9 B 405 GLY THR GLY SER PHE GLY ARG VAL MET LEU VAL LYS HIS SEQRES 10 B 405 LYS GLU THR GLY ASN HIS TYR ALA MET LYS ILE LEU ASP SEQRES 11 B 405 LYS GLN LYS VAL VAL LYS LEU LYS GLN ILE GLU HIS THR SEQRES 12 B 405 LEU ASN GLU LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO SEQRES 13 B 405 PHE LEU VAL LYS LEU GLU PHE SER PHE LYS ASP ASN SER SEQRES 14 B 405 ASN LEU TYR MET VAL MET GLU TYR VAL PRO GLY GLY GLU SEQRES 15 B 405 MET PHE SER HIS LEU ARG ARG ILE GLY ARG PHE SER GLU SEQRES 16 B 405 PRO HIS ALA ARG PHE TYR ALA ALA GLN ILE VAL LEU THR SEQRES 17 B 405 PHE GLU TYR LEU HIS SER LEU ASP LEU ILE TYR ARG ASP SEQRES 18 B 405 LEU LYS PRO GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR SEQRES 19 B 405 ILE GLN VAL THR ASP PHE GLY PHE ALA LYS ARG VAL LYS SEQRES 20 B 405 GLY ARG THR TRP TPO LEU CYS GLY THR PRO GLU TYR LEU SEQRES 21 B 405 ALA PRO GLU ILE ILE LEU SER LYS GLY TYR ASN LYS ALA SEQRES 22 B 405 VAL ASP TRP TRP ALA LEU GLY VAL LEU ILE TYR GLU MET SEQRES 23 B 405 ALA ALA GLY TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE SEQRES 24 B 405 GLN ILE TYR GLU LYS ILE VAL SER GLY LYS VAL ARG PHE SEQRES 25 B 405 PRO SER HIS PHE SER SER ASP LEU LYS ASP LEU LEU ARG SEQRES 26 B 405 ASN LEU LEU GLN VAL ASP LEU THR LYS ARG PHE GLY ASN SEQRES 27 B 405 LEU LYS ASN GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP SEQRES 28 B 405 PHE ALA THR THR ASP TRP ILE ALA ILE TYR GLN ARG LYS SEQRES 29 B 405 VAL GLU ALA PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY SEQRES 30 B 405 ASP THR SER ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE SEQRES 31 B 405 ARG VAL SEP ILE ASN GLU LYS CYS GLY LYS GLU PHE SER SEQRES 32 B 405 GLU PHE SEQRES 1 J 20 THR THR TYR ALA ASP PHE ILE ALA SER GLY ARG THR GLY SEQRES 2 J 20 ARG ARG ASN ALA ILE HIS ASP MODRES 8FEC SEP A 194 SER MODIFIED RESIDUE MODRES 8FEC TPO A 252 THR MODIFIED RESIDUE MODRES 8FEC SEP A 393 SER MODIFIED RESIDUE MODRES 8FEC TPO B 252 THR MODIFIED RESIDUE MODRES 8FEC SEP B 393 SER MODIFIED RESIDUE HET SEP A 194 10 HET TPO A 252 11 HET SEP A 393 10 HET TPO B 252 11 HET SEP B 393 10 HET XU0 A 501 22 HET XU0 B 501 22 HETNAM SEP PHOSPHOSERINE HETNAM TPO PHOSPHOTHREONINE HETNAM XU0 6-[(6P)-6-(4-BROMO-1-METHYL-1H-IMIDAZOL-5-YL)-2,3- HETNAM 2 XU0 DIHYDRO-4H-1,4-THIAZIN-4-YL]-7H-PURINE HETSYN SEP PHOSPHONOSERINE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 SEP 3(C3 H8 N O6 P) FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 5 XU0 2(C13 H12 BR N7 S) HELIX 1 AA1 ASP A 3 LEU A 8 1 6 HELIX 2 AA2 SER A 15 TYR A 30 1 16 HELIX 3 AA3 ALA A 40 ASP A 56 1 17 HELIX 4 AA4 ASP A 56 ASP A 64 1 9 HELIX 5 AA5 ASP A 64 SER A 87 1 24 HELIX 6 AA6 HIS A 94 ASP A 96 5 3 HELIX 7 AA7 LYS A 131 LEU A 137 1 7 HELIX 8 AA8 GLN A 139 VAL A 153 1 15 HELIX 9 AA9 GLU A 182 ILE A 190 1 9 HELIX 10 AB1 SEP A 194 LEU A 215 1 22 HELIX 11 AB2 LYS A 223 GLU A 225 5 3 HELIX 12 AB3 THR A 256 LEU A 260 5 5 HELIX 13 AB4 ALA A 261 LEU A 266 1 6 HELIX 14 AB5 LYS A 272 GLY A 289 1 18 HELIX 15 AB6 GLN A 297 GLY A 308 1 12 HELIX 16 AB7 SER A 317 LEU A 328 1 12 HELIX 17 AB8 VAL A 343 ASN A 348 1 6 HELIX 18 AB9 HIS A 349 ALA A 353 5 5 HELIX 19 AC1 ASP A 356 GLN A 362 1 7 HELIX 20 AC2 THR I 6 SER I 13 1 8 HELIX 21 AC3 ASP B 3 LEU B 8 1 6 HELIX 22 AC4 SER B 15 ARG B 29 1 15 HELIX 23 AC5 HIS B 31 ASN B 35 5 5 HELIX 24 AC6 GLY B 39 ASP B 56 1 18 HELIX 25 AC7 ASP B 56 SER B 87 1 32 HELIX 26 AC8 HIS B 94 ASP B 96 5 3 HELIX 27 AC9 LYS B 131 LEU B 137 1 7 HELIX 28 AD1 GLN B 139 GLN B 151 1 13 HELIX 29 AD2 GLU B 182 GLY B 191 1 10 HELIX 30 AD3 SER B 194 LEU B 215 1 22 HELIX 31 AD4 LYS B 223 GLU B 225 5 3 HELIX 32 AD5 THR B 256 LEU B 260 5 5 HELIX 33 AD6 ALA B 261 LEU B 266 1 6 HELIX 34 AD7 LYS B 272 GLY B 289 1 18 HELIX 35 AD8 GLN B 297 GLY B 308 1 12 HELIX 36 AD9 SER B 317 LEU B 328 1 12 HELIX 37 AE1 ASP B 331 ARG B 335 5 5 HELIX 38 AE2 VAL B 343 ASN B 348 1 6 HELIX 39 AE3 HIS B 349 ALA B 353 5 5 HELIX 40 AE4 ASP B 356 ARG B 363 1 8 HELIX 41 AE5 THR J 6 SER J 13 1 8 SHEET 1 AA1 5 PHE A 98 THR A 106 0 SHEET 2 AA1 5 ARG A 111 HIS A 117 -1 O LYS A 116 N GLU A 99 SHEET 3 AA1 5 HIS A 123 ASP A 130 -1 O ILE A 128 N ARG A 111 SHEET 4 AA1 5 ASN A 170 GLU A 176 -1 O LEU A 171 N LEU A 129 SHEET 5 AA1 5 LEU A 161 LYS A 166 -1 N PHE A 165 O TYR A 172 SHEET 1 AA2 2 LEU A 217 ILE A 218 0 SHEET 2 AA2 2 LYS A 244 ARG A 245 -1 O LYS A 244 N ILE A 218 SHEET 1 AA3 2 LEU A 227 ILE A 229 0 SHEET 2 AA3 2 ILE A 235 VAL A 237 -1 O GLN A 236 N LEU A 228 SHEET 1 AA4 5 PHE B 98 GLY B 105 0 SHEET 2 AA4 5 ARG B 111 HIS B 117 -1 O LYS B 116 N GLU B 99 SHEET 3 AA4 5 HIS B 123 ASP B 130 -1 O ILE B 128 N ARG B 111 SHEET 4 AA4 5 ASN B 170 GLU B 176 -1 O MET B 175 N ALA B 125 SHEET 5 AA4 5 LEU B 161 LYS B 166 -1 N GLU B 162 O VAL B 174 SHEET 1 AA5 2 LEU B 217 ILE B 218 0 SHEET 2 AA5 2 LYS B 244 ARG B 245 -1 O LYS B 244 N ILE B 218 SHEET 1 AA6 2 LEU B 227 ILE B 229 0 SHEET 2 AA6 2 ILE B 235 VAL B 237 -1 O GLN B 236 N LEU B 228 LINK C PHE A 193 N SEP A 194 1555 1555 1.33 LINK C SEP A 194 N GLU A 195 1555 1555 1.33 LINK C TRP A 251 N TPO A 252 1555 1555 1.34 LINK C TPO A 252 N LEU A 253 1555 1555 1.32 LINK C VAL A 392 N SEP A 393 1555 1555 1.33 LINK C SEP A 393 N ILE A 394 1555 1555 1.33 LINK C TRP B 251 N TPO B 252 1555 1555 1.33 LINK C TPO B 252 N LEU B 253 1555 1555 1.32 LINK C VAL B 392 N SEP B 393 1555 1555 1.33 LINK C SEP B 393 N ILE B 394 1555 1555 1.33 CRYST1 50.640 59.100 91.008 88.95 86.14 89.86 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019747 -0.000048 -0.001332 0.00000 SCALE2 0.000000 0.016921 -0.000308 0.00000 SCALE3 0.000000 0.000000 0.011015 0.00000